- Home
- MYFW vs TIL Comparison
MYFW vs TIL Comparison
Compare MYFW & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- TIL
- Stock Information
- Founded
- MYFW 2002
- TIL 2018
- Country
- MYFW United States
- TIL United States
- Employees
- MYFW N/A
- TIL N/A
- Industry
- MYFW Major Banks
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- TIL Health Care
- Exchange
- MYFW Nasdaq
- TIL Nasdaq
- Market Cap
- MYFW 201.1M
- TIL 177.1M
- IPO Year
- MYFW 2018
- TIL 2021
- Fundamental
- Price
- MYFW $23.50
- TIL $24.10
- Analyst Decision
- MYFW Buy
- TIL Buy
- Analyst Count
- MYFW 2
- TIL 6
- Target Price
- MYFW $24.25
- TIL $120.50
- AVG Volume (30 Days)
- MYFW 25.9K
- TIL 140.2K
- Earning Date
- MYFW 10-23-2025
- TIL 11-12-2025
- Dividend Yield
- MYFW N/A
- TIL N/A
- EPS Growth
- MYFW 226.95
- TIL N/A
- EPS
- MYFW 1.18
- TIL N/A
- Revenue
- MYFW $93,514,000.00
- TIL N/A
- Revenue This Year
- MYFW $14.41
- TIL N/A
- Revenue Next Year
- MYFW $12.25
- TIL N/A
- P/E Ratio
- MYFW $19.91
- TIL N/A
- Revenue Growth
- MYFW 16.68
- TIL N/A
- 52 Week Low
- MYFW $17.10
- TIL $10.80
- 52 Week High
- MYFW $24.88
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- MYFW 61.14
- TIL 42.77
- Support Level
- MYFW $21.31
- TIL $22.67
- Resistance Level
- MYFW $23.74
- TIL $33.83
- Average True Range (ATR)
- MYFW 0.58
- TIL 2.45
- MACD
- MYFW 0.09
- TIL -0.55
- Stochastic Oscillator
- MYFW 90.12
- TIL 12.81
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.